CD46 and cancer: Overall, our data provides evidence that the variables without CD46 are suitable for diagnostic patients with grade 1 iCCA and superior for prognosticating with the grade 1 iCCA and the grade 1 HCCs, and can also be appropriate for cancer grade 2/3 iCCA/HCCs patients.